We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+21.97%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.4B
AUM Growth
+$2.42B
Cap. Flow
-$2.83B
Cap. Flow %
-7.57%
Top 10 Hldgs %
11.88%
Holding
2,717
New
342
Increased
802
Reduced
1,205
Closed
360

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$350M
2
ZM icon
Zoom
ZM
+$327M
3
META icon
Meta Platforms (Facebook)
META
+$261M
4
PTON icon
Peloton Interactive
PTON
+$234M
5
SNAP icon
Snap
SNAP
+$217M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$412M
2
PYPL icon
PayPal
PYPL
+$372M
3
LLY icon
Eli Lilly
LLY
+$283M
4
BMY icon
Bristol-Myers Squibb
BMY
+$242M
5
BA icon
Boeing
BA
+$227M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Consumer Discretionary 16.66%
3 Healthcare 12.88%
4 Consumer Staples 9.06%
5 Financials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEN
2351
DELISTED
Genesis Healthcare, Inc.
GEN
$14K ﹤0.01%
+29,400
New +$14.8K
BGI icon
2352
Birks Group
BGI
$9.07M
$13K ﹤0.01%
+15,200
New +$12.2K
BRQS
2353
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$13K ﹤0.01%
+67
New +$13.8K
MKD
2354
DELISTED
Molecular Data Inc. American Depositary Shares
MKD
$12K ﹤0.01%
+927
New +$15.2K
DYNT
2355
DELISTED
Dynatronics Corp
DYNT
$11K ﹤0.01%
2,660
-1,620
-38% -$5.74K
ATOS icon
2356
Atossa Therapeutics
ATOS
$22.8M
$10K ﹤0.01%
720
-93
-11% -$2.15K
AVGR
2357
DELISTED
Avinger, Inc. Common Stock
AVGR
$8K ﹤0.01%
+63
New +$5.71K
A icon
2358
Agilent Technologies
A
$39.5B
-12,200
Closed -$1.23M
AAOI icon
2359
Applied Optoelectronics
AAOI
$6.35B
-57,000
Closed -$641K
AAP icon
2360
Advance Auto Parts
AAP
$3.49B
-107,300
Closed -$16.5M
ABG icon
2361
Asbury Automotive
ABG
$4.67B
-5,100
Closed -$497K
ABUS icon
2362
Arbutus Biopharma
ABUS
$845M
-24,100
Closed -$75K
ADBE icon
2363
Adobe
ADBE
$105B
-9,600
Closed -$4.71M
ADEA icon
2364
Adeia
ADEA
$2.58B
-73,048
Closed -$222K
ADT icon
2365
ADT
ADT
$5.4B
-205,200
Closed -$1.68M
AGIO icon
2366
Agios Pharmaceuticals
AGIO
$2.08B
-38,200
Closed -$1.34M
AIV
2367
Aimco
AIV
$378M
-1,759,580
Closed -$7.9M
AJG icon
2368
Arthur J. Gallagher & Co
AJG
$69.1B
-54,400
Closed -$5.74M
AKAM icon
2369
Akamai
AKAM
$15.8B
-2,700
Closed -$298K
ALE
2370
DELISTED
Allete
ALE
-14,500
Closed -$750K
ALOT icon
2371
AstroNova
ALOT
$224M
-18,500
Closed -$148K
AMAT icon
2372
Applied Materials
AMAT
$354B
-240,042
Closed -$14.3M
AMN icon
2373
AMN Healthcare
AMN
$1.36B
-6,200
Closed -$362K
AMRX icon
2374
Amneal Pharmaceuticals
AMRX
$6.02B
-47,249
Closed -$183K
ANVS icon
2375
Annovis Bio
ANVS
$71.9M
-13,300
Closed -$64K

Similar funds

Two Sigma Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Two Sigma Advisers held 2,717 positions worth $37.4B, up 6.9% from $35B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Two Sigma Advisers withdrew a net $2.83B in Q4 2020, closing 360 positions and reducing 1,205 holdings. Its most notable exit was Danaher, an estimated $189M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Two Sigma Advisers opened a new position in NVIDIA worth $341M.

  • Two Sigma Advisers's largest Q4 2020 buy was NVIDIA: 26,132,000 shares worth $341M.
  • Two Sigma Advisers added most to Zoom in Q4 2020, an estimated $327M increase.
  • Two Sigma Advisers's biggest Q4 2020 reduction was Tesla, cutting an estimated $412M.
  • Two Sigma Advisers fully exited Danaher in Q4 2020, selling an estimated $189M.
  • Two Sigma Advisers's ten largest holdings make up 12% of its $37.4B portfolio in Q4 2020.
  • Two Sigma Advisers opened 342 new positions and closed 360 in Q4 2020.
  • Two Sigma Advisers's portfolio value rose 6.9% quarter-over-quarter to $37.4B.

Based on Two Sigma Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.